Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Apexigen Inc.
DescriptionHumanized mAb which inhibits interleukin-1-beta
Molecular Target Interleukin-1 (IL-1) beta
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Inflammation (unspecified)
Indication DetailsTreat inflammation
Regulatory Designation
PartnerJiangsu T-mab BioPharma Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today